Martin Vazquez - 01 Aug 2022 Form 4 Insider Report for Outset Medical, Inc. (OM)

Role
Chief Operating Officer
Signature
By: John L Brottem For: Martin Vazquez
Issuer symbol
OM
Transactions as of
01 Aug 2022
Net transactions value
-$161,200
Form type
4
Filing time
02 Aug 2022, 17:14:47 UTC
Previous filing
02 Jun 2022
Next filing
16 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OM Common Stock Options Exercise $19,400 +5,000 +10% $3.88* 54,237 01 Aug 2022 Direct
transaction OM Common Stock Sale $100,000 -5,000 -9.2% $20.00 49,237 01 Aug 2022 Direct F1
transaction OM Common Stock Options Exercise $19,400 +5,000 +10% $3.88* 54,237 01 Aug 2022 Direct
transaction OM Common Stock Sale $100,000 -5,000 -9.2% $20.00 49,237 01 Aug 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OM Performance Options (right to buy) Options Exercise $0 -5,000 -4.6% $0.000000 103,007 01 Aug 2022 Common Stock 5,000 $3.88 Direct F2
transaction OM Performance Options (right to buy) Options Exercise $0 -5,000 -4.9% $0.000000 98,007 01 Aug 2022 Common Stock 5,000 $3.88 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2022.
F2 In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested.